Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Oncology Reports|November 8, 2006
Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancerKouji Banno, Megumi Yanokura, Nobuyuki Susumu, et al.
Journal of Gynecologic Oncology|May 12, 2025
Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patientsShoko Kitazawa, Kensuke Sakai, Miho Kawaida, et al.
Current Genomics|October 2, 2009
Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review)Kouji Banno, Megumi Yanokura, Yusuke Kobayashi, et al.
Epigenomics|March 28, 2012
Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practiceKouji Banno, Iori Kisu, Megumi Yanokura, et al.
Japanese Journal of Clinical Oncology|September 4, 2013
Hypertriglyceridemia is frequent in endometrial cancer survivorsAkira Hirasawa, Kazuya Makita, Tomoko Akahane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancerAkira Hirasawa, Daisuke Aoki, Jun Inoue, et al.
Anticancer Research|August 17, 2005
Successful analysis of anticancer drug sensitivity by CD-DST using pleural fluid and ascites from patients with advanced ovarian cancer: case reportsMakiko Kawaguchi, Kouji Banno, Nobuyuki Susumu, et al.
Gynecologic Oncology|December 1, 2007
A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinomaSachiko Ezawa, Nao Suzuki, Shinji Ohie, et al.
Oncology Reports|December 5, 2006
Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancerMegumi Yanokura, Kouji Banno, Makiko Kawaguchi, et al.
Journal of Gynecologic Oncology|May 24, 2024
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)Kensuke Sakai, Wataru Yamagami, Yasunori Sato, et al.
Pageof 13